Effectiveness of Botulinum Toxin Injection in the Tennis Elbow Treatment

Record History

See every version on ClinicalTrials.gov ↗

1. May 11, 2026 Study Status, Referencesv6
2. Notable Feb 27, 2013 Primary completion date changed from estimate of Jul 2011 to Jun 2012

   • Trial status: Recruiting to Completed
   • Enrollment target: estimated 60 to confirmed 61
   • Site details revised

   v5
3. Minor Apr 12, 2011 Primary completion date: Mar 2011 to Jul 2011

   • Study completion date: Dec 2011 to Jun 2012

   v4
4. Notable Dec 30, 2010 Primary completion date: Mar 2009 to Mar 2011

   • Study completion date: Dec 2009 to Dec 2011
   • Site contact updated
   • Eligibility criteria expanded, about 5 words

   v3
5. Notable Sep 3, 2008 Phase: Phase 4 to Phase 3v2 Show 12 more changesShow less

   • Trial status: Not Yet Recruiting to Recruiting
   • Primary endpoint revised
   • Primary completion date: Mar 2009
   • Study completion date: Dec 2009
   • Start date: Mar 2007 to Apr 2007
   • Interventions: Dysport (Botulinum A Toxin) (Drug) to Botulinum Toxin A Injection (Drug), Placebo injection (Drug)
   • Eligibility criteria revised
   • Secondary endpoints: 1 to 5
   • Study description revised
   • Site details revised
   • Study title revised
   • Study arms: 0 to 2
6. Feb 20, 2007 Study First Submitted

• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.